Persones / Equip Humà

Cinzia Emilia Lavarino

Buscador de publicacions

Publicacions

  • Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and Ciudad CJ.

    Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

    Oligonucleotides . 14(2): 100-113. Nº de cites: 59

    [doi:10.1089/1545457041526290]

  • Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA and Pilotti S.

    Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.

    INTERNATIONAL JOURNAL OF CANCER . 92(6): 790-796. Nº de cites: 44

    [doi:10.1002/ijc.1271]

  • Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA and Pilotti S.

    Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.

    LABORATORY INVESTIGATION . 81(6): 833-844. Nº de cites: 92

    [doi:10.1038/labinvest.3780293]

  • Lavarino C, Pilotti S, Oggionni M, Gatti L, Perego P, Bresciani G, Pierotti MA, Scambia G, Ferrandina G, Fagotti A, Mangioni C, Lucchini V, Vecchione F, Bolis G, Scarfone G and Zunino F.

    p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.

    JOURNAL OF CLINICAL ONCOLOGY . 18(23): 3936-3945. Nº de cites: 125

    [doi:10.1200/JCO.2000.18.23.3936]

  • Butò S, Pierotti MA, Tamborini E, Della Torre G, Lavarino C, Rilke F and Pilotti S.

    Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.

    DIAGN MOL PATHOL . 8(3): 125-130. Nº de cites: 14

    [doi:10.1097/00019606-199909000-00004]

  • Di Palma S, Corletto V, Lavarino C, Birindelli S and Pilotti S.

    Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland.

    VIRCHOWS ARCHIV . 434(4): 361-365. Nº de cites: 39

    [doi:10.1007/s004280050353]

  • Pilotti S, Lavarino C, Mezzelani A, Della Torre C, Minoletti F, Sozzi G, Azzarelli A, Rilke F and Pierotti MA.

    Limited role of TP53 and TP53-related genes in myxoid liposarcoma.

    Tumori . 84(5): 571-577. Nº de cites: 17

    [doi:10.1177/030089169808400512]

  • Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F and Pierotti MA.

    Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.

    JOURNAL OF PATHOLOGY . 185(2): 188-190. Nº de cites: 81

    [doi:10.1002/(SICI)1096-9896(199806)185:2<188::AID-PATH53>3.0.CO;2-2]

  • Lavarino C, Corletto V, Mezzelani A, Della Torre G, Bartoli C, Riva C, Pierotti MA, Rilke F and Pilotti S.

    Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma.

    BRITISH JOURNAL OF CANCER . 77(1): 125-130. Nº de cites: 33

    [doi:10.1038/bjc.1998.20]

  • Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A, Rilke F and Pierotti MA.

    Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.

    JOURNAL OF PATHOLOGY . 181(1): 14-24. Nº de cites: 134

    [doi:10.1002/(SICI)1096-9896(199701)181:1<14::AID-PATH730>3.0.CO;2-O]